About NeuAngel Biopharmaceuticals, Inc.
NeuAngel Biopharmaceuticals, Inc. is building differentiated CNS therapeutics. By pairing AI-driven discovery with expert medicinal chemistry and clinically proven targets, the team designs selective drugs for dementia-related-psychosis, where no therapies are approved. Millions of patients face a critical unmet need and NeuAngel is positioned to solve this problem.